DK1140090T3 - Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt - Google Patents
Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigtInfo
- Publication number
- DK1140090T3 DK1140090T3 DK00900025T DK00900025T DK1140090T3 DK 1140090 T3 DK1140090 T3 DK 1140090T3 DK 00900025 T DK00900025 T DK 00900025T DK 00900025 T DK00900025 T DK 00900025T DK 1140090 T3 DK1140090 T3 DK 1140090T3
- Authority
- DK
- Denmark
- Prior art keywords
- phanquinone
- prevention
- treatment
- memory failure
- failure
- Prior art date
Links
- 229960003606 phanquinone Drugs 0.000 title 1
- VLPADTBFADIFKG-UHFFFAOYSA-N phanquone Chemical compound C1=CN=C2C(=O)C(=O)C3=NC=CC=C3C2=C1 VLPADTBFADIFKG-UHFFFAOYSA-N 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR99100005 | 1999-01-07 | ||
EP00900025A EP1140090B1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
PCT/IB2000/000011 WO2000040244A1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1140090T3 true DK1140090T3 (da) | 2005-04-18 |
Family
ID=10943706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00900025T DK1140090T3 (da) | 1999-01-07 | 2000-01-06 | Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt |
Country Status (17)
Country | Link |
---|---|
US (1) | US7030136B2 (da) |
EP (1) | EP1140090B1 (da) |
JP (1) | JP2002534386A (da) |
AR (1) | AR022215A1 (da) |
AT (1) | ATE285235T1 (da) |
AU (1) | AU1792200A (da) |
BR (1) | BR0008241A (da) |
CA (1) | CA2358487C (da) |
DE (1) | DE60016892T2 (da) |
DK (1) | DK1140090T3 (da) |
ES (1) | ES2234559T3 (da) |
HK (1) | HK1042039B (da) |
IL (1) | IL143903A (da) |
PT (1) | PT1140090E (da) |
SI (1) | SI1140090T1 (da) |
TR (1) | TR200101892T2 (da) |
WO (1) | WO2000040244A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69805305T2 (de) | 1997-08-21 | 2002-12-05 | P.N. Gerolymatos S.A., Kruoneri | Verwendung von phanquinon zur behandlung von alzheimer's krankheit |
WO2001082912A2 (en) * | 2000-04-28 | 2001-11-08 | Gerolymatos P N Sa | TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING PHANQUINONE |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472257A (en) | 1973-09-10 | 1977-05-04 | Christiaens Sa A | Derivative of 4-hydroxy-5-azacoumarin |
PH25025A (en) * | 1986-12-17 | 1991-01-28 | Glaxo Group Ltd | A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one |
US5091391A (en) * | 1990-08-16 | 1992-02-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of resisting neurodegenerative disorders |
DE69227380T3 (de) | 1991-11-12 | 2007-01-11 | Prana Biotechnology Ltd., South Melbourne | Verfahren zur bestimmung und behandlung von alzheimer-krankheit |
US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
AU1153097A (en) | 1996-06-07 | 1998-01-05 | Eisai Co. Ltd. | Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production |
HUP9903906A3 (en) * | 1996-08-13 | 2001-01-29 | Gerolymatos P N Sa | Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
EP1007048A4 (en) | 1997-03-11 | 2004-09-22 | Gen Hospital Corp | IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE |
DE69805305T2 (de) * | 1997-08-21 | 2002-12-05 | P.N. Gerolymatos S.A., Kruoneri | Verwendung von phanquinon zur behandlung von alzheimer's krankheit |
US5980914A (en) * | 1997-08-22 | 1999-11-09 | P.N. Gerolymatos S.A. | Clioquinol for the treatment of Parkinson's disease |
US5994323A (en) * | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
-
2000
- 2000-01-06 AT AT00900025T patent/ATE285235T1/de not_active IP Right Cessation
- 2000-01-06 SI SI200030621T patent/SI1140090T1/xx unknown
- 2000-01-06 WO PCT/IB2000/000011 patent/WO2000040244A1/en not_active Application Discontinuation
- 2000-01-06 IL IL14390300A patent/IL143903A/en not_active IP Right Cessation
- 2000-01-06 BR BR0008241-4A patent/BR0008241A/pt not_active Application Discontinuation
- 2000-01-06 JP JP2000592001A patent/JP2002534386A/ja active Pending
- 2000-01-06 CA CA002358487A patent/CA2358487C/en not_active Expired - Fee Related
- 2000-01-06 PT PT00900025T patent/PT1140090E/pt unknown
- 2000-01-06 AR ARP000100046A patent/AR022215A1/es unknown
- 2000-01-06 TR TR2001/01892T patent/TR200101892T2/xx unknown
- 2000-01-06 EP EP00900025A patent/EP1140090B1/en not_active Expired - Lifetime
- 2000-01-06 ES ES00900025T patent/ES2234559T3/es not_active Expired - Lifetime
- 2000-01-06 DK DK00900025T patent/DK1140090T3/da active
- 2000-01-06 AU AU17922/00A patent/AU1792200A/en not_active Abandoned
- 2000-01-06 DE DE60016892T patent/DE60016892T2/de not_active Expired - Fee Related
-
2002
- 2002-03-15 US US10/098,922 patent/US7030136B2/en not_active Expired - Fee Related
- 2002-04-10 HK HK02102678.3A patent/HK1042039B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE285235T1 (de) | 2005-01-15 |
CA2358487A1 (en) | 2000-07-13 |
DE60016892T2 (de) | 2005-12-15 |
EP1140090B1 (en) | 2004-12-22 |
PT1140090E (pt) | 2005-05-31 |
HK1042039B (zh) | 2005-07-29 |
WO2000040244A1 (en) | 2000-07-13 |
JP2002534386A (ja) | 2002-10-15 |
HK1042039A1 (en) | 2002-08-02 |
US7030136B2 (en) | 2006-04-18 |
DE60016892D1 (de) | 2005-01-27 |
IL143903A0 (en) | 2002-04-21 |
CA2358487C (en) | 2008-11-18 |
BR0008241A (pt) | 2001-10-30 |
TR200101892T2 (tr) | 2001-11-21 |
AR022215A1 (es) | 2002-09-04 |
US20030055078A1 (en) | 2003-03-20 |
IL143903A (en) | 2004-02-08 |
SI1140090T1 (en) | 2005-06-30 |
EP1140090A1 (en) | 2001-10-10 |
ES2234559T3 (es) | 2005-07-01 |
AU1792200A (en) | 2000-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1427437T3 (da) | Oxyntomodulin til forebyggelse eller behandling af overvægt | |
DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
DK1181027T3 (da) | Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK2412368T3 (da) | Sammensætning til behandling af ar | |
NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
DK1143977T3 (da) | 2-oxy-benzoxazinonderivater til behandling af obesitas | |
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
NO995500L (no) | Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi | |
NO990722D0 (no) | FremgangsmÕte for behandling av hjertesvikt | |
DK1278540T3 (da) | Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose | |
DK1411917T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser | |
DK199800837A (da) | Anlæg til behandling af emner | |
DK1041985T3 (da) | Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme | |
DK1218022T3 (da) | Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba | |
DK1173179T3 (da) | Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse | |
DK1534296T3 (da) | Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt | |
DK1140090T3 (da) | Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt | |
DE50006862D1 (de) | Gerüsttragvorrichtung | |
DK1157987T3 (da) | S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser | |
DK1064014T3 (da) | Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor | |
ATA70499A (de) | Plattenförmiger sicherheitsbauteil | |
DK199900400U3 (da) | System til beskyttelse af træværk | |
ATE256408T1 (de) | Bauelement zur errichtung von regalen | |
DE50013770D1 (de) | Fassaden-Gerüst |